The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis

International Journal of Radiation Oncology Biology Physics

Volumn 46, Issue 1, 2000, Pages 221-230

  Nag, Subir ^a,b   Bice, William ^a,c   DeWyngaert, Keith ^a,d   Prestidge, Bradley ^a,e   Stock, Richard ^a,f   Yu, Yan ^a,g  

^a The American Brachytherapy Society   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e University of Texas Health Science Center at San Antonio   (United States)

^f MOUNT SINAI HOSPITAL   (United States)

^g UNIVERSITY OF ROCHESTER   (United States)

Author keywords

103Palladium; 125Iodine; Brachytherapy; Dosimetry; Guidelines; Prostate neoplasm

Indexed keywords

IODINE 125; PALLADIUM;

ARTICLE; BRACHYTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; TUMOR VOLUME;

EID: 0033976043     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00351-X     Document Type: Article

References (76)

1. Prete JJ, Prestidge BR, Bice WS; et al. A survey of physics and dosimetry practice of permanent prostate brachytherapy in the United States. Int J Radiat Oncol Biol Phys 1998;40:1001-1005.
2. Nag S, Baird M, Blasko J; et al. American Brachytherapy Society (ABS) survey of current clinical practice for permanent brachytherapy of prostate cancer. J Brachyther Int 1997;13:243-251.
3. Nag S, Beyer D, Friedland J; et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys.1999;44:789-799.
4. 125I prostate implants. Int J Radiat Oncol Biol Phys. 34:1996;717-725.
5. Waterman F.M., Yue N., Corn B.W., et al. Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry An analysis based on serial CT acquisition . Int J Radiat Oncol Biol Phys. 41:1998;1069-1077.
6. Willins J., Wallner K. CT-based dosimetry for transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 39:1997;347-353.
7. Bice WS, Prestidge BR, Grimm PD; et al. Centralized multi-institutional post-implant analysis for interstitial prostate brachytherapy. Int J Radiat Oncol Biol Phys 1998;41:921-927.
8. Dawson J.E., Wu T., Roy T., et al. Dose effects of seed placement deviations from pre-planned positions in ultrasound guided prostate implants. Radiother Oncol. 32:1994;268-270.
9. Narayana V, Roberson PL, Winfield RJ; et al. Optimal placement of radioisotopes for permanent prostate implants. Radiology 1996;199:457-460.
10. Roberson PL, Narayana V, McShan DL; et al. Source placement error for permanent implant of the prostate. Med Phys 1997;24:251-257.
11. Stock R.G., Stone N., Tabert A., et al. A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys. 41:1998;101-108.
12. Lerner SE, Blute ML, Zincke H. Critical evaluation of salvage surgery for radiorecurrent/resistant prostate cancer. J Urol 1995;154:1103-1109.
13. Stock RG, Stone NN. Salvage brachytherapy for recurrent prostate cancer following radiation therapy. In: Zelefsky, Greco C, editors. Radiotherapy of prostate cancer. United Kingdom: Harwood Academic. In press.
14. Grado GL, Collins JM, Kriegshauser JS; et al. Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 1999;53:2-10.
15. Prestidge B.R., Bice W.S., Prete J.J., et al. A dose-volume analysis of permanent transperineal prostate brachytherapy. (Abstr.) Int J Radiat Oncol Biol Phys. 39:1997;289.
16. Sharkey J., Chovnick S.D., Behar R.J., et al. Outpatient ultrasound-guided palladium-103 brachytherapy for localized adenocarcinoma of the prostate A preliminary report of 434 patients . Urology. 51:1998;796-803.
17. Stone N.N., Stock R.G., DeWyngaert J.K., et al. Prostate brachytherapy Improvements in prostate volume measurements and dose distribution using interactive ultrasound guided implantation and three-dimensional dosimetry . Radiat Oncol Invest. 3:1995;185-195.
18. Roy J.N., Wallner K.E., Harrington P.J., et al. A CT-based evaluation method for permanent implants Application to prostate . Int J Radiat Oncol Biol Phys. 26:1993;163-169.
19. Altschuler M.D., Findlay P.A., Epperson R.D. Rapid accurate three-dimensional location of multiple seeds in implant radiotherapy treatment planning. Phys Med Biol. 28:1983;1305-1318.
20. Siddon R.L., Chin L.M. Med Phys. 12:1985;77-83.
21. Metz C., Fencil L.E. Determination of three dimensional structure in biplane radiography with prior knowledge of the relationship between the two views Theory . Med Phys. 16:1989;45-51.
22. Hughes H.A. Accuaracy of foreign body localization from tube shift radiographs. Br J Radiol. 29:1956;116-118.
23. Rosen I.I., Khan K.M., Lane R.G., et al. The effect of geometric errors in the reconstruction of iridium-192 seed implants. Med Phys. 9:1982;220-223.
24. Fitzgerald L.T., Mauderli W. Analysis of errors in three-dimensional reconstruction of radium implants from stereo radiographs. Radiology. 115:1975;455-458.
25. Amols H.I. Rosen II. A three-film technique for reconstruction of radioactive seed implants Med Phys. 8:1981;210-214.
26. Biggs PJ, Kelley DM. Geometric reconstruction of seed implants using a three-film technique. Med Phys 1983;10:701-704.
27. Altschuler M.D., Kassaee A. Automatic matching of corresponding seed images of three simulator radigraphs to allow 3-D triangulation of implanted seeds. Phys Med Biol. 42:1997;293-302.
28. Brinkman D.H. Kline RW. Automated seed localization from CT data sets of the prostate. Med Phys. 25:1998;1667-1672.
29. Bice WS, Dubois DF, Prete JJ; et al. Source localization from axial image sets by iterative relaxation of the nearest neighbor criterion. Med Phys Submitted.
30. Dubois D.F., Prestidge B.R., Hotchkiss L.A., et al. Intraobserver and interobserver variability of MR imaging and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. Radiology. 207:1998;785-789.
31. Moerland M.A., Wijrdeman H.K., Beersma R., et al. Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 37:1997;927-933.
32. Dubois D.F., Prestidge B.R., Hotchkiss L.A., et al. Source localization following permanent transperineal prostate interstitial brachytherapy using magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 39:1997;1037-1041.
33. Narayana V., Roberson P.L., Pu A.T., et al. Impact of differences in ultrasound and computed tomography volumes on treatment planning of permanent prostate implants. Int J Radiat Oncol Biol Phys. 37:1997;1181-1185.
34. Narayana V., Roberson P.L., Winfield R.J., et al. Impact of ultrasound and computed tomography prostate volume registration on evaluation of permanent prostate implants. Int J Radiat Oncol Biol Phys. 39:1997;341-346.
35. Dubois DF, Bice WS, Prestidge BR; et al. CT and MRI derived source localization error in a custom prostate phantom using automated image coregistration. Med Phys. In press.
36. Amdur R., Gladstone D., Leopold K., et al. Prostate seed implant quality assessment using MR and CT image fusion. Int J Radiat Oncol Biol Phys. 43:1999;67-72.
37. Bice WS, Freeman JE, Russell J; et al. Coregistration of post-implant ultrasound and CT image sets in permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. Submitted.
38. Nag S., Scaperoth D.D., Badalament R., et al. Transperineal palladium-103 prostate brachytherapy: Analysis of morbidity and seed migration Urology. 45:1995;87-92.
39. Tapen EM, Blasko JC, Grimm PD; et al. Reduction of radioactive seed embolization to the lung following prostate brachytherapy. Int J Radiat Oncol Biol Phys 1998;42:1063-1067.
40. Steinfeld AD, Donahue BR, Plaine L. Pulmonary embolization of iodine-125 seeds following prostate implantation. Urology 1991;37:149.
41. Nag S., Vivekanandam S., Monge R. Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 39:1997;667-670.
42. Stock R.G., Stone N.N., Wesson M.F., et al. A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys. 32:1995;219-225.
43. Bice W.S., Prestidge B.R. A review of postimplant quality assessment in permanent transperineal interstitial prostate brachytherapy. J Brachyther Int. 13:1997;297-313.
44. Badiozamani K.R., Wallner K., Cavanagh W., et al. Comparability of CT-based and TRUS-based prostate volumes. Int J Radiat Oncol Biol Phys. 43:1999;375-378.
45. Nath R., Anderson L.L., Luxton G., et al. Dosimetry of interstitial brachytherapy sources Recommendations of the AAPM Radiation Committee Task Group No. 43 . Med Phys. 22:1995;209-234.
46. 125I transperineal prostate seed implants on commercial treatment planning systems. Int J Radiat Oncol Biol Phys 1997;37:737-741.
47. 125I. Int J Radiat Oncol Biol Phys 1998;40:1237-1241.
48. Williamson J., Coursey B., DeWerd L., et al. Dosimetric prerequisites for routine clinical use of new low energy photon interstitial brachytherapy sources. Med Phys. 25:1998;2269-2270.
49. Yu Y, Anderson LL, Li Z; et al. Permanent prostate seed implant brachytherapy: Report of the American Association of Physicists in Medicine Task Group No. 64. Med Phys. In press.
50. Anderson L.L. Brachytherapy planning and evaluation. Endocurie Hyperther Oncol. 7:1991;139-146.
51. Roach M., Akazawa P., Malfatti C., et al. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 35:1996;1011-1018.
52. Wallner K., Roy J., Harrison L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 32:1995;465-471.
53. DeWyngaert J.K., Wesson M.F. Treatment planning considerations of ultrasound guided I-125 prostate implants. Int J Radiat Oncol Biol Phys. 21:(Suppl. 1):1991;160.
54. Desai J., Stock R.G., Stone N.N., et al. Acute urinary morbidity following iodine-125 interstitial implantation of the prostate gland. Radiat Oncol Invest. 6:1998;135-141.
55. Waterman FM, Dicker AP. Determination of the urethral dose in prostate brachytherapy when the urethra is not visualized in the post-implant CT scan. (Abstr.) Med Phys. In press.
56. Lu Y., Li S., Spelbring D., et al. Dose-surface histograms as treatment planning tool for prostate conformal therapy. Med Phys. 22:1995;279-284.
57. Zelefsky M.J., Happersett L., Leibel S., et al. The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 37:1997;13-19.
58. Prestidge B.R., Bice W.S., Kiefer E.J., et al. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy. Int J Radiat Oncol Biol Phys. 40:1998;1111-1115.
59. Merrick G.S., Butler W.M., Dorsey A.T., et al. Influence of timing on the dosimetric analysis of transperineal ultrasound-guided prostatic conformal brachytherapy. Radiat Oncol Invest. 6:1998;182-190.
60. Yue N., Nath R., Chen Z., et al. Optimum timing for CT-based dose evaluation of I-125 and Pd-103 prostate seed implants. (Abstr.) Int J Radiat Oncol Biol Phys. 42:1998;134.
61. 103Pd seed implant of prostate. Int J Radiat Oncol Biol Phys 1999;43:447-454.
62. Moerland M.A. The effect of edema on post-implant dosimetry of permanent iodine-125 prostate implants A simulation study . J Brachyther Int. 14:1998;225-231.
63. Willins J., Wallner K. Time-dependent changes in CT-based dosimetry of I-125 prostate brachytherapy. Radiat Oncol Invest. 6:1998;157-160.
64. Yu Y. A non-divergent specification of the mean treatment dose in interstitial brachytherapy. Med Phys. 23:1996;905-909.
65. Riet A., Loo H.J., Ypma A.F., et al. Ultrasonically guided transperineal seed implantation of the prostate Modification of the technique and qualitative assessment of implants . Int J Radiat Oncol Biol Phys. 24:1992;555-558.
66. Anderson L. Brachytherapy planning and evaluation. Endocurie Hypertherm Oncol. 7:1991;139-146.
67. Paul J, Philip P, Brandenburg R; et al. Histograms in brachytherapy. Endocurie Hypertherm Oncol 1991;7:13-26.
68. 125I boost therapy. Med Phys. 10:1983;155-158.
69. Riet A., Mak A.C., Moerland M.A., et al. A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation Application to the prostate . Int J Radiat Oncol Biol Phys. 37:1997;731-736.
70. Saw C.B., Suntharalingam N. Quantitative assessment of interstitial implants. Int J Radiat Oncol Biol Phys. 20:1991;135-139.
71. 125iodine implantation of the prostate for clinically localized prostatic cancer. J Urol. 158:1997;23-29.
72. Nath R, Roberts K, Ng M; et al. Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine-125 interstitial implants. Med Phys 1998;25:2293-2307.
73. 125I implantation . Int J Radiat Oncol Biol Phys. 21:1991;537-547.
74. 125I seeds . Int J Radiat Oncol Biol Phys. 28:1994;971-978.
75. Burns G., Raeside D. The accuracy of single-seed dose superposition of I-125 implants. Med Phys. 16:1989;627-631.
76. 125I brachytherapy implants. Med Phys. 19:1992;385-390.